Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics

Respiratory Medicine

Volumn 92, Issue 1, 1998, Pages 44-49

  Bisgaard, H ^a   Nikander, K ^b   Munch, E ^c  

^a Rigshospitalet   (Denmark)

^b ASTRAZENECA R AND D   (Sweden)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; HYDROCORTISONE;

ADULT; ARTICLE; ASTHMA; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INHALATIONAL DRUG ADMINISTRATION; MALE; METERED DOSE INHALER; NEBULIZATION; PARTICLE SIZE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM;

EID: 0031913574     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90031-2     Document Type: Article

References (21)

1. Godfrey S, Avital A, Rosler A, Mandelberg A, Uwyyed K. Nebulized budesonide in severe infantile asthma. Lancet 1987; 2: 851-852.
2. Carlsen KH, Leegaard J, Larsen S, Ørstavik I. Nebulized beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis. Arch Dis Child 1988; 63: 1428-1433.
3. Ilangovan P, Pedersen S, Godfrey S, Nikander K, Noviski N, Warner JO. Treatment of severe steroid dependent preschool asthma with nebulized budesonide suspension. Arch Dis Child 1993; 68: 356-359.
4. Birk-Madsen E, Bundgaard A, Hidinger K-G. Cumulative dose-response study comparing terbutaline pressurized aerosol administration via a pearshaped spacer and terbutaline in a nebulized solution. Eur J Clin Pharmacol 1982; 23: 27-30.
5. Stauder J. Hidinger K-G. Terbutaline aerosol from a metered dose inhaler with a 750 mL spacer or as a nebulized solution. Comparison of two delivery systems for bonchodilator aerosol. Respiration 1983; 44: 237-240.
6. Pedersen JZ, Bundgaard A. Comparative efficacy of different methods of nebulising terbutaline. Eur J Clin Pharmacol 1983; 25: 739-742.
7. Choo-Kang YFJ, Grant IW. Comparison of two methods of administering bronchodilator aerosol to asthmatic patients. Br Med J 1975; 2: 119-120.
8. Christensson P, Arborelius M, Lilja B. Salbutamol inhalation in chronic asthma bronchiale: dose aerosol vs jet nebulizer. Chest 1981; 79: 416-4519.
9. Weber RW, Petty WE, Nelson HS. Aerosolized terbutaline in asthmatics. Comparison of dosage strength, schedule and method of administration. J Allergy Clin Irnmunol 1979; 63: 116-121.
10. Allen MB, Pugh J, Wilson RSE. Nebuhaler® or nebulizer for high dose bronchodilator therapy in chronic bronchitis: a comparison. Br J Disc Chest 1988; 82: 368-373.
11. Gunawardena KA, Smityh AP, Shankleman J. A comparison of metered dose inhaler with nebulizers for the delivery of ipratropium bromide in domiciliary practice. Br J Dis Chest 1986; 80: 170-178.
12. Lewis RA, Cushley MJ, Fleming JS, Tattersfield AE. Is a nebulizer less efficient than a metered dose inhaler and do pearshaped extension tubes work? Am Rev Respir Dis 1982; 125: 94.
13. Lewis RA, Fleming JS. Fractional deposition from a jet nebulizer: how it differs from a metered dose inhaler. Br J Dis Chest 1985; 79: 361-367.
14. Zainudin BM, Biddiscombe M, Tolfree SE, Shorts M, Spiro SG. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebulized solution. Thorax 1990; 45: 469-473.
15. Toogood JH. Bronchial asthma and glucocorticoids. In: Anti-inflammatory Steroid Action. Basic and Clinical Aspects. Academic Press, 1989: 435-440.
16. Weinberger M. Antiasthmatic therapy in children. Pediatr Clin North Am 1989; 36: 1251-1284.
17. Bisgaard H, Anhøj J, Klug B, Berg E. A non-electrostatic spacer for aerosol delivery. Arch Dis Childhood 1995; 73: 226-230.
18. Dahlström K, Larsson P. Lung deposition and systemic availability of budesonide inhaled as nebulised suspension from different nebulisers. J Aer Med 1995; 8: 47. (Abstract).
19. Hadfield JW, Windebank WJ, Bateman JR. Is driving gas flow rate clinically important for nebulizer therapy? Br J Dis Chest 1986; 80: 50-54.
20. Douglas JG, Leslie MJ, Compton GK, Grant IWB. Is the flow rate used to drive a jet nebulizer clinically important? BMJ 1985; 290: 29.
21. Summers QA. Inhaled drugs and the lung Clin Exp Allergy 1991; 21: 259-268.